Disorders of iron metabolism, N. Engl. J. Med, vol.341, 1986. ,
Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, vol.388, pp.482-488, 1997. ,
An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron, Science, vol.291, pp.1755-1759, 2001. ,
Identification of an intestinal heme transporter, Cell, vol.122, pp.789-801, 2005. ,
Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption, Cell, vol.127, pp.917-928, 2006. ,
Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin, Clin. Nutr. Edinb. Scotl, vol.36, pp.1427-1433, 2017. ,
Iron absorption. I. Factors influencing absorption, J. Lab. Clin. Med, vol.51, pp.24-36, 1958. ,
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation, Mol. Cell, vol.5, pp.299-309, 2000. ,
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter, Nature, vol.403, pp.776-781, 2000. ,
A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J. Biol. Chem, vol.275, 2000. ,
The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum, J. Biol. Chem, pp.2746-2751, 1966. ,
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse, Nat. Genet, vol.21, pp.195-199, 1999. ,
Transferrin receptor is necessary for development of erythrocytes and the nervous system, Nat. Genet, vol.21, pp.396-399, 1999. ,
Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells, Nat. Genet, vol.37, pp.1264-1269, 2005. ,
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22, Nat. Genet, vol.25, pp.14-15, 2000. ,
Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TFR2) in intestinal tissue and cells, J. Histochem. Cytochem, vol.51, pp.613-624, 2003. ,
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity, FEBS Lett, vol.480, pp.147-150, 2000. ,
Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J. Biol. Chem, vol.276, pp.7806-7810, 2001. ,
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload, J. Biol. Chem, vol.276, pp.7811-7819, 2001. ,
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, vol.306, pp.2090-2093, 2004. ,
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc. Natl. Acad. Sci, vol.98, pp.8780-8785, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-00331349
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J. Clin. Investig, vol.113, pp.1271-1276, 2004. ,
A New Iron Regulatory Peptide, Blood Cells Mol. Dis, vol.29, pp.327-335, 2002. ,
Role of the hypoxia inducible factors HIF in iron metabolism, Cell Cycle, vol.7, pp.28-32, 2008. ,
Identification of erythroferrone as an erythroid regulator of iron metabolism, Nat. Genet, vol.46, pp.678-684, 2014. ,
Expression of hepcidin in hereditary hemochromatosis: Evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron, Blood, vol.102, pp.371-376, 2003. ,
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes, Haematologica, vol.94, pp.765-772, 2009. ,
The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression, J. Biol. Chem, vol.272, pp.14025-14028, 1997. ,
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding, Proc. Natl. Acad. Sci, vol.95, pp.1472-1477, 1998. ,
The transferrin receptor modulates HFE-dependent regulation of hepcidin expression, Cell Metab, vol.7, pp.205-214, 2008. ,
Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing, J. Biol. Chem, vol.281, pp.28494-28498, 2006. ,
Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2, Am. J. Hematol, vol.87, pp.588-595, 2012. ,
Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat. Genet, vol.41, pp.478-481, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00385005
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism, Nat. Genet, vol.41, pp.482-487, 2009. ,
Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD, J. Mol. Med, vol.87, pp.471-480, 2009. ,
A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis, Haematologica, vol.94, pp.720-724, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00372237
Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice, vol.129, pp.405-414, 2017. ,
Bmp6 expression in murine liver non parenchymal cells: A mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?, PLoS ONE, vol.10, 2015. ,
Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis, vol.129, pp.415-419, 2017. ,
A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab, vol.2, pp.399-409, 2005. ,
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver, Blood, vol.112, pp.1503-1509, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00298517
A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells, J. Mol. Med, vol.86, pp.531-540, 2008. ,
The hemochromatosis proteins HFE, TFR2, and HJV form a membrane-associated protein complex for hepcidin regulation, J. Hepatol, vol.57, pp.1052-1060, 2012. ,
Iron regulation of hepcidin through HFE and HJV: Common or distinct pathways? Hepatology, vol.62, pp.1922-1923, 2015. ,
Iron metabolism and related genetic diseases: A cleared land, keeping mysteries, J. Hepatol, vol.64, pp.505-515, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01231421
Rare HFE variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis, Am. J. Hematol, vol.91, pp.1202-1205, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01427007
, Nat. Rev. Dis. Primer, 2018.
Iron-overload-related disease in HFE hereditary hemochromatosis, N. Engl. J. Med, vol.358, pp.221-230, 2008. ,
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels, Br. J. Haematol, vol.142, pp.979-985, 2008. ,
Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress, Proc. Natl. Acad. Sci, vol.93, pp.8175-8182, 1996. ,
Cellular iron metabolism, Kidney Int. Suppl, vol.69, 1999. ,
The transferrin receptor: Role in health and disease, Int. J. Biochem. Cell Biol, vol.31, pp.1111-1137, 1999. ,
The importance of eukaryotic ferritins in iron handling and cytoprotection, Biochem. J, vol.472, pp.1-15, 2015. ,
Non-transferrin plasma iron, Br. J. Haematol, vol.66, pp.149-151, 1987. ,
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method, J. Hepatol, vol.32, pp.727-733, 2000. ,
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy, J. Biol. Chem, vol.264, pp.4417-4422, 1989. ,
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells, Proc. Natl. Acad. Sci, vol.103, pp.13612-13617, 2006. ,
Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states, J. Clin. Investig, vol.76, pp.1463-1470, 1985. ,
Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats, Hepatology, vol.25, pp.1457-1461, 1997. ,
Regulation of ferritin and transferrin receptor expression by iron in human hepatocyte cultures, J. Hepatol, vol.18, pp.301-312, 1993. ,
Transferrin receptor expression in rat liver: Immunohistochemical and biochemical analysis of the effect of age and iron storage, Hepatology, vol.11, pp.416-427, 1990. ,
SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis, Cell Metab, vol.22, pp.138-150, 2015. ,
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis, Nat. Genet, vol.33, pp.221-222, 2003. ,
Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis, Nat. Genet, vol.36, pp.77-82, 2004. ,
Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: Novel observations, Br. J. Haematol, vol.162, pp.278-281, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00836894
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis, N. Engl. J. Med, vol.313, pp.1256-1262, 1985. ,
Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, vol.110, pp.1107-1119, 1996. ,
Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients, J. Hepatol, vol.16, pp.122-127, 1992. ,
Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis, Gastroenterology, vol.115, pp.929-936, 1998. ,
Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations, Gastroenterology, vol.102, pp.2050-2059, 1992. ,
Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-1072, 2012. ,
The role of iron and reactive oxygen species in cell death, Nat. Chem. Biol, vol.10, pp.9-17, 2014. ,
TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload, Am. J. Physiol, vol.267, pp.908-913, 1994. ,
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis, Gastroenterology, vol.107, pp.1118-1124, 1994. ,
Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases, Gastroenterology, vol.104, pp.228-234, 1993. ,
Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: The bone and the joint, Best Pract. Res. Clin. Rheumatol, vol.25, pp.6649-6664, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01134838
Fenton chemistry: An introduction, Radiat. Res, vol.145, pp.523-531, 1996. ,
Hepatic injury in chronic iron overload. Role of lipid peroxidation, Chem. Biol. Interact, vol.70, pp.183-226, 1989. ,
Hepatic lipid peroxidation in vivo in rats with chronic iron overload, J. Clin. Investig, vol.71, pp.429-439, 1983. ,
Hepatic mitochondrial energy production in rats with chronic iron overload, Gastroenterology, vol.105, pp.1134-1140, 1993. ,
Redox active plasma iron in C282Y/C282Y hemochromatosis, Blood, vol.105, pp.4527-4531, 2005. ,
LPI-labile plasma iron in iron overload, Best Pr. Res. Clin. Haematol, vol.18, pp.277-287, 2005. ,
Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance, Am. J. Hum. Genet, vol.81, pp.799-807, 2007. ,
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis, J. Hepatol, vol.62, pp.664-672, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01091987
Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload, Hepatology, vol.62, pp.429-439, 2015. ,
GNPAT polymorphism rs11558492 is not associated with increased severity in a large cohort of HFE p.Cys282Tyr homozygous patients, Hepatology, vol.65, pp.1069-1071, 2017. ,
GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis, Ann. Hepatol, vol.15, pp.907-910, 2016. ,
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors, Ann. Hepatol, vol.16, pp.451-456, 2017. ,
Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis, Gastroenterology, vol.122, pp.281-289, 2002. ,
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis, Hepatology, vol.46, pp.723-729, 2007. ,
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma, J. Hepatol, vol.58, pp.190-193, 2013. ,
Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection, J. Hepatol, vol.36, pp.687-691, 2002. ,
Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis, Hum. Mol. Genet, vol.23, pp.3883-3890, 2014. ,
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis, World J. Gastroenterol, vol.18, pp.2813-2820, 2012. ,
Contributors and Hemochromatosis International Taskforce Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, Hepatol. Int, vol.12, pp.83-86, 2018. ,
Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases, Hepatology, vol.44, pp.472-477, 2006. ,
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis, Hepatology, vol.52, pp.1671-1779, 2010. ,
Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy, J. Clin. Apheresis, vol.31, pp.564-570, 2016. ,
NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy, Haematologica, vol.98, 2013. ,
Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis, Gut, vol.43, pp.699-704, 1998. ,
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1, Nat. Med, vol.13, pp.448-454, 2007. ,
Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial, Gastroenterology, vol.153, pp.678-680, 2017. ,
Articular cartilage in the degenerative arthropathy of hemochromatosis, Arthritis Rheum, vol.25, pp.1460-1468, 1982. ,
Synovial immunopathology in haemochromatosis arthropathy, Ann. Rheum. Dis, vol.69, pp.1214-1219, 2010. ,
Ferritin concentrations in synovial fluid are higher in osteoarthritis patients with HFE gene mutations (C282Y or H63D), Scand. J. Rheumatol, vol.39, pp.413-420, 2010. ,
The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system, Immun. Inflamm. Dis, vol.5, pp.218-232, 2017. ,
Worse Outcomes of Patients with HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy, Clin. Gastroenterol. Hepatol, vol.15, pp.1620-1627, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01613515
Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis, Hepatology, vol.59, pp.839-847, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00876626
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload, J. Clin. Investig, vol.121, pp.4880-4888, 2011. ,
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in HFE knockout mice, Gastroenterology, vol.139, pp.1721-1729, 2010. ,
Reducing TMPRSS6 ameliorates hemochromatosis and ?-thalassemia in mice, J. Clin. Investig, vol.123, pp.1531-1541, 2013. ,
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction, Front. Pharmacol, vol.8, 2017. ,